IJR.AX - iShares S&P Small-Cap ETF
| Previous Close | 110.98 |
| Open | 110.00 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 108.54 - 110.00 |
| 52 Week Range | 94.42 - 127.50 |
| Volume | 3,299 |
| Avg. Volume | N/A |
| Net Assets | N/A |
| NAV | N/A |
| PE Ratio (TTM) | N/A |
| Yield | N/A |
| YTD Return | N/A |
| Beta (3Y Monthly) | N/A |
| Expense Ratio (net) | N/A |
| Inception Date | N/A |
- Market Realist•4 months ago
Aveo Pharmaceuticals Stock Fell More than 60% on January 31
Aveo Pharmaceuticals Stock Fell More than 60% on January 31Share price movementsOn January 31, Aveo Pharmaceuticals (AVEO) issued a press release announcing its decision not to file an NDA (new drug application) for its drug, Fotivda (tivozanib),
- Market Realist•4 months ago
Why iRobot Stock Has Surged ~5% Today
Why iRobot Stock Has Surged ~5% TodayiRobot stockToday, iRobot (IRBT) stock surged 5.3% before the market opened. At 9:50 AM Eastern Time, it was up 3.7%, while the S&P 500 and the NASDAQ Composite had risen 0.5% and 0.8%, respectively.
Market Realist•8 months agoA Financial Overview of Supernus Pharmaceuticals in September
In the second quarter, Supernus Pharmaceuticals (SUPN) reported net revenues of $99.5 million compared to $75.8 million in the second quarter of 2017. In the first half, Supernus Pharmaceuticals generated net revenues of $190.0 million compared to $133.4 million in the first half of 2017.
